Preemie study sparks debate over risks of research

Doctors frequently prescribe one treatment over another without any evidence to know which option works best, and they don't have to tell their patients that they're essentially guessing.

But when researchers study which commonly used option is best, they're supposed to outline all the risks.

A says a controversial study of didn't properly do that, setting off debate about how much patients really need to know when enrolling in this kind of research.

Some critics say full disclosure is an ethical must. But others say that could mislead patients into thinking research is riskier than their own doctor's best guess.

Federal health officials convened a meeting Wednesday to hear from the public on how to handle the disclosures.

Explore further

US says preemie study didn't fully disclose risks

© 2013 The Associated Press. All rights reserved.

Citation: Preemie study sparks debate over risks of research (2013, August 29) retrieved 29 January 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors